Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Antidepressants are drugs used for the treatment of major depressive disorder and other conditions, including dysthymia, anxiety disorders, obsessive–compulsive disorder, eating disorders, chronic pain, neuropathic pain and, in some cases, dysmenorrhoea, snoring, migraine, attention-deficit hyperactivity disorder (ADHD), addiction, dependence, and sleep disorders. They may be prescribed alone or in combination with other medications.
The report details the trend, potential and market size of Anti-depressant market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Anti-depressantmarket, defines the market attractiveness level of Anti-depressant market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Anti-depressant industry, describes the types of Anti-depressant market, the applications of major players and the market size, and deeply analyzes the current situation of the global Anti-depressant market and the development prospects and opportunities of Anti-depressant industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Anti-depressant market in Chapter 13.
By Player:
GlaxoSmithKline
Allergan
Lundbeck
Merck
Eli Lilly and Company
TEVA PHARMACEUTICAL INDUSTRIES
Alkermes
TAKEDA PHARMACEUTICAL
Pfizer
Bristol-Myers Squibb
By Type:
Tricyclic Antidepressants
Selective Serotonin Reuptake Inhibitors
Serotonin-Norepinephrine Reuptake Inhibitors
Monoamine Oxidase Inhibitors
Serotonin Antagonist
Reuptake Inhibitors
Others
By End-User:
Major Depressive Disorder
Obsessive-compulsive Disorder
Generalized Anxiety Disorder
Panic Disorder
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Anti-depressant Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Anti-depressant Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Anti-depressant Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Anti-depressant Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Anti-depressant Market Analysis and Outlook to 2022
-
7.1 Global Anti-depressant Consumption (2017-2022)
-
7.2 United States Anti-depressant Consumption (2017-2022)
-
7.3 Europe Anti-depressant Consumption (2017-2022)
-
7.4 China Anti-depressant Consumption (2017-2022)
-
7.5 Japan Anti-depressant Consumption (2017-2022)
-
7.6 India Anti-depressant Consumption (2017-2022)
-
7.7 South Korea Anti-depressant Consumption (2017-2022)
8 Region and Country-wise Anti-depressant Market Analysis and Outlook to 2028
-
8.1 Global Anti-depressant Consumption Forecast (2022-2028)
-
8.2 United States Anti-depressant Consumption Forecast (2022-2028)
-
8.3 Europe Anti-depressant Consumption Forecast (2022-2028)
-
8.4 China Anti-depressant Consumption Forecast (2022-2028)
-
8.5 Japan Anti-depressant Consumption Forecast (2022-2028)
-
8.6 India Anti-depressant Consumption Forecast (2022-2028)
-
8.7 South Korea Anti-depressant Consumption Forecast (2022-2028)
9 Global Anti-depressant Market Outlook by Types and Applications to 2022
-
9.1 Global Anti-depressant Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Tricyclic Antidepressants Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Selective Serotonin Reuptake Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Serotonin-Norepinephrine Reuptake Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Monoamine Oxidase Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Serotonin Antagonist Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Reuptake Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Anti-depressant Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Major Depressive Disorder Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Obsessive-compulsive Disorder Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Generalized Anxiety Disorder Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Panic Disorder Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Others Consumption and Growth Rate (2017-2022)
10 Global Anti-depressant Market Outlook by Types and Applications to 2028
-
10.1 Global Anti-depressant Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Tricyclic Antidepressants Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Selective Serotonin Reuptake Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Serotonin-Norepinephrine Reuptake Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Monoamine Oxidase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Serotonin Antagonist Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Reuptake Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.7 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Anti-depressant Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Major Depressive Disorder Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Obsessive-compulsive Disorder Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Generalized Anxiety Disorder Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Panic Disorder Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Anti-depressant Import and Export Analysis (Top 5 Countries)
-
11.1 Global Anti-depressant Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Anti-depressant Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Anti-depressant Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Anti-depressant Market Competitive Analysis
-
14.1 GlaxoSmithKline
-
14.1.1 GlaxoSmithKline Company Details
-
14.1.2 GlaxoSmithKline Anti-depressant Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 GlaxoSmithKline Anti-depressant Product and Service
-
14.2 Allergan
-
14.2.1 Allergan Company Details
-
14.2.2 Allergan Anti-depressant Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Allergan Anti-depressant Product and Service
-
14.3 Lundbeck
-
14.3.1 Lundbeck Company Details
-
14.3.2 Lundbeck Anti-depressant Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Lundbeck Anti-depressant Product and Service
-
14.4 Merck
-
14.4.1 Merck Company Details
-
14.4.2 Merck Anti-depressant Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Merck Anti-depressant Product and Service
-
14.5 Eli Lilly and Company
-
14.5.1 Eli Lilly and Company Company Details
-
14.5.2 Eli Lilly and Company Anti-depressant Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Eli Lilly and Company Anti-depressant Product and Service
-
14.6 TEVA PHARMACEUTICAL INDUSTRIES
-
14.6.1 TEVA PHARMACEUTICAL INDUSTRIES Company Details
-
14.6.2 TEVA PHARMACEUTICAL INDUSTRIES Anti-depressant Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 TEVA PHARMACEUTICAL INDUSTRIES Anti-depressant Product and Service
-
14.7 Alkermes
-
14.7.1 Alkermes Company Details
-
14.7.2 Alkermes Anti-depressant Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Alkermes Anti-depressant Product and Service
-
14.8 TAKEDA PHARMACEUTICAL
-
14.8.1 TAKEDA PHARMACEUTICAL Company Details
-
14.8.2 TAKEDA PHARMACEUTICAL Anti-depressant Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 TAKEDA PHARMACEUTICAL Anti-depressant Product and Service
-
14.9 Pfizer
-
14.9.1 Pfizer Company Details
-
14.9.2 Pfizer Anti-depressant Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Pfizer Anti-depressant Product and Service
-
14.10 Bristol-Myers Squibb
-
14.10.1 Bristol-Myers Squibb Company Details
-
14.10.2 Bristol-Myers Squibb Anti-depressant Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Bristol-Myers Squibb Anti-depressant Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Anti-depressant
-
Figure Anti-depressant Picture
-
Table Global Anti-depressant Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anti-depressant Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anti-depressant Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Anti-depressant Consumption by Country (2017-2022)
-
Figure United States Anti-depressant Consumption and Growth Rate (2017-2022)
-
Table Europe Anti-depressant Consumption and Growth Rate (2017-2022)
-
Figure China Anti-depressant Consumption and Growth Rate (2017-2022)
-
Figure Japan Anti-depressant Consumption and Growth Rate (2017-2022)
-
Figure India Anti-depressant Consumption and Growth Rate (2017-2022)
-
Figure South Korea Anti-depressant Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-depressant Consumption Forecast by Country (2022-2028)
-
Figure United States Anti-depressant Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Anti-depressant Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Anti-depressant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Anti-depressant Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Anti-depressant Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Anti-depressant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tricyclic Antidepressants Consumption and Growth Rate (2017-2022)
-
Figure Global Selective Serotonin Reuptake Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Serotonin-Norepinephrine Reuptake Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Monoamine Oxidase Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Serotonin Antagonist Consumption and Growth Rate (2017-2022)
-
Figure Global Reuptake Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Major Depressive Disorder Consumption and Growth Rate (2017-2022)
-
Figure Global Obsessive-compulsive Disorder Consumption and Growth Rate (2017-2022)
-
Figure Global Generalized Anxiety Disorder Consumption and Growth Rate (2017-2022)
-
Figure Global Panic Disorder Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Tricyclic Antidepressants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Selective Serotonin Reuptake Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Serotonin-Norepinephrine Reuptake Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Monoamine Oxidase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Serotonin Antagonist Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Reuptake Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Major Depressive Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Obsessive-compulsive Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Generalized Anxiety Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Panic Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Anti-depressant Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Anti-depressant Export by Region (Top 5 Countries) (2017-2028)
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Anti-depressant Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Anti-depressant Product and Service
-
Table Allergan (Foundation Year, Company Profile and etc.)
-
Table Allergan Anti-depressant Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Anti-depressant Product and Service
-
Table Lundbeck (Foundation Year, Company Profile and etc.)
-
Table Lundbeck Anti-depressant Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lundbeck Anti-depressant Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Anti-depressant Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Anti-depressant Product and Service
-
Table Eli Lilly and Company (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly and Company Anti-depressant Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly and Company Anti-depressant Product and Service
-
Table TEVA PHARMACEUTICAL INDUSTRIES (Foundation Year, Company Profile and etc.)
-
Table TEVA PHARMACEUTICAL INDUSTRIES Anti-depressant Sales, Price, Value and Gross Profit (2017-2022)
-
Table TEVA PHARMACEUTICAL INDUSTRIES Anti-depressant Product and Service
-
Table Alkermes (Foundation Year, Company Profile and etc.)
-
Table Alkermes Anti-depressant Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alkermes Anti-depressant Product and Service
-
Table TAKEDA PHARMACEUTICAL (Foundation Year, Company Profile and etc.)
-
Table TAKEDA PHARMACEUTICAL Anti-depressant Sales, Price, Value and Gross Profit (2017-2022)
-
Table TAKEDA PHARMACEUTICAL Anti-depressant Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Anti-depressant Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Anti-depressant Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Anti-depressant Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Anti-depressant Product and Service
-
